|
ZNF187 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15805151526638E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02109998234567E-09 |
| Normal-vs-Stage2 |
2.07429999998787E-06 |
| Normal-vs-Stage3 |
1.19529941500218E-11 |
| Normal-vs-Stage4 |
2.42829978347459E-10 |
| Stage1-vs-Stage2 |
7.532800E-01 |
| Stage1-vs-Stage3 |
1.775710E-02 |
| Stage1-vs-Stage4 |
1.117830E-02 |
| Stage2-vs-Stage3 |
1.814040E-01 |
| Stage2-vs-Stage4 |
7.118200E-02 |
| Stage3-vs-Stage4 |
4.915400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34765548615223E-12 |
| Normal-vs-AfricanAmerican |
1.73397999999603E-05 |
| Normal-vs-Asian |
4.049000E-04 |
| Caucasian-vs-AfricanAmerican |
5.585800E-01 |
| Caucasian-vs-Asian |
3.404500E-02 |
| AfricanAmerican-vs-Asian |
5.246100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.23080048562019E-10 |
| Normal-vs-Female |
4.43234338121101E-12 |
| Male-vs-Female |
6.270000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.32670019204318E-10 |
| Normal-vs-Age(41-60Yrs) |
8.93380036615099E-10 |
| Normal-vs-Age(61-80Yrs) |
9.62999679998688E-11 |
| Normal-vs-Age(81-100Yrs) |
2.161200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.460000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.022760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.889600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.936440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.891400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.223800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.54121000000007E-05 |
| Classical-VS-Follicular |
2.375500E-02 |
| Classical-VS-Other |
6.408400E-01 |
| Classical-VS-Normal |
5.96329985391719E-10 |
| Tall-VS-Follicular |
2.086000E-02 |
| Tall-VS-Other |
1.486620E-01 |
| Tall-VS-Normal |
2.32724950421925E-12 |
| Follicular-VS-Other |
3.710200E-01 |
| Follicular-VS-Normal |
3.979599982884E-10 |
| Other-VS-Normal |
1.533640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.49610048980765E-10 |
| Normal-vs-N1 |
2.27499996618974E-09 |
| N0-vs-N1 |
1.254840E-01 |
|
|
